Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Seagen Inc.

Start price
Target price
Perf. (%)
€52.00
10.10.17
€54.12
11.10.17
4.91%
11.10.17

buy
Nuvasive Inc.

Start price
Target price
Perf. (%)
€68.97
05.07.17
€71.71
20.07.17
4.58%
20.07.17

buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€2.61
05.07.17
€2.80
14.07.17
27.25%
14.07.17

buy
Paratek Pharma

Start price
Target price
Perf. (%)
€14.25
02.03.17
€20.20
10.04.17
43.35%
10.04.17

buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€136.85
21.11.16
€150.00
21.02.17
10.28%
21.02.17

buy
Humana Inc.

Start price
Target price
Perf. (%)
€158.54
23.09.16
€180.40
14.11.16
14.31%
14.11.16

buy
Ekso Bionics Holdings Inc.

Start price
Target price
Perf. (%)
€50.51
13.09.16
€60.00
28.09.16
20.94%
28.09.16

buy
Portola Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€36.33
03.06.15
€40.00
07.12.15
23.06%
07.12.15

buy
Medicines Co.

Start price
Target price
Perf. (%)
€24.58
18.02.15
€28.00
07.09.15
45.81%
07.09.15

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.55
01.10.14
€2.00
01.04.15
110.38%
01.04.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€86.15
28.11.14
€92.00
23.01.15
6.79%
23.01.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€86.15
28.11.14
€92.00
23.01.15
6.79%
23.01.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€13.18
30.01.12
€30.00
11.05.12
302.12%
11.05.12

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Celgene Corp.

Start price
Target price
Perf. (%)
€20.81
04.05.08
€22.00
18.09.08
6.80%
18.09.08